99418-15-2Relevant articles and documents
COMBINATIONS OF HEPATITIS C VIRUS INHIBITORS
-
Page/Page column 721; 722, (2015/02/02)
The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein.